114 related articles for article (PubMed ID: 17829)
1. Binding of a conformationally restricted dopamine analogue, 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, to receptors on rat brain synaptic membranes.
Roberts PJ; Woodruff GN; Poat JA
Mol Pharmacol; 1977 May; 13(3):541-7. PubMed ID: 17829
[No Abstract] [Full Text] [Related]
2. ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene): a prototype for possible dopaminergic false transmitters?
Roberts PJ; Davis A
Adv Biochem Psychopharmacol; 1978; 19():177-91. PubMed ID: 696460
[No Abstract] [Full Text] [Related]
3. Stereospecific binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain dopamine receptors [proceedings].
Davis A; Poat JA; Woodruff GN
Biochem Soc Trans; 1979 Feb; 7(1):147-8. PubMed ID: 437261
[No Abstract] [Full Text] [Related]
4. Identification and localization of the recognition binding subunit of the D1 dopamine receptor.
Tanaka C; Kuno T; Mita T; Ishibe T
Adv Biochem Psychopharmacol; 1983; 36():135-45. PubMed ID: 6858751
[No Abstract] [Full Text] [Related]
5. Coupling of neurotransmitter receptors with an adenylate cyclase. A tool for studying their pharmacological properties, distribution and modulation in the central nervous system.
Bockaert J
J Physiol (Paris); 1978; 74(5):527-33. PubMed ID: 218000
[No Abstract] [Full Text] [Related]
6. Binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain synaptic membranes: association with the dopamine (3,4-dihydroxyphenethylamine) receptor.
Roberts PJ; Woodruff GN; Poat JA
Biochem Soc Trans; 1976; 4(2):316-7. PubMed ID: 1001677
[No Abstract] [Full Text] [Related]
7. Effect of calmodulin on catecholamine-linked adenylate cyclase activity in rat striatum and cerebral cortex.
Gnegy ME; Hultin T; Treisman G
Adv Biochem Psychopharmacol; 1980; 21():125-31. PubMed ID: 6246737
[No Abstract] [Full Text] [Related]
8. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
Spano PF; Memo M; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
[No Abstract] [Full Text] [Related]
9. [3H] 2-Amino-6,7-dihydroxy 1,2,3,4-tetrahydronapthalene (ADTN): a potential specific dopamine receptor ligand.
Clement-Cormier Y; Abel M
Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):15-25. PubMed ID: 725314
[TBL] [Abstract][Full Text] [Related]
10. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
11. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and dopamine receptors binding affinity of 2-(3-fluoro-4-hydroxyphenyl)ethylamine and its N-alkyl derivatives.
Cardellini M; Cingolani GM; Claudi F; Perlini V; Balduini W; Cattabeni F
Farmaco Sci; 1988 Jan; 43(1):49-59. PubMed ID: 2899520
[TBL] [Abstract][Full Text] [Related]
13. [Dependence of the antipsychotic effect of neuroleptics on their dopamine-blocking properties].
Arushanian EB
Farmakol Toksikol; 1982; 45(5):118-26. PubMed ID: 6128251
[No Abstract] [Full Text] [Related]
14. Regulation of dopamine-dependent adenylate cyclase by a Ca++ binding protein stored in synaptic membranes.
Costa E; Gnegy M; Revuelta A; Uzunov P
Adv Biochem Psychopharmacol; 1977; 16():403-8. PubMed ID: 18889
[No Abstract] [Full Text] [Related]
15. Detection of multiple receptors for dopamine.
Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
[No Abstract] [Full Text] [Related]
16. Binding of [3H]amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat striatal membranes. Effects of purine nucleotides and ultraviolet irradiation.
Zahniser NR; Heidenreich KA; Molinoff PB
Mol Pharmacol; 1981 May; 19(3):372-8. PubMed ID: 7266464
[No Abstract] [Full Text] [Related]
17. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
18. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
19. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
Clement-Cormier Y
Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
[No Abstract] [Full Text] [Related]
20. The use of ADTN (2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene) as a ligand for brain dopamine receptors [proceedings].
Cross AJ; Crow TJ; Owen F
Br J Pharmacol; 1979 May; 66(1):87P. PubMed ID: 454971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
